Feng He

stanford university school of medicine

H指数:23

被引数:2,201

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Elucidating EGCG’ s targets in nasopharyngeal carcinoma through combined cell-based assays and transcriptomic sequencing

通过结合基于细胞的实验和转录组测序，阐明EGCG在鼻咽癌中的靶点。

Discover Oncology

IF2.9

2026-02-200

OAAI

Inactivation of Acetyl-CoA Acyltransferase 1 enhances the proliferation and motility of nasopharyngeal carcinoma cells

乙酰辅酶A酰基转移酶1的失活增强了鼻咽癌细胞的增殖和迁移能力

Molecular & Cellular Oncology

IF1.9

2025-11-170

OAAI

HRA00184-C004, preclinical characterization of a novel tissue factor-targeted antibody-drug conjugate

CANCER RESEARCH

IF16.6

2024-03-220

PRE

HRA00242-C004, a novel anti-PSMA ADC with high DAR reveals potent in vitro and in vivo anti-tumor efficacy

CANCER RESEARCH

IF16.6

2024-03-221

PRE

HRA00130-C004, a novel anti-DLL3 ADC with bystander effect, high DAR and favorable safety profiles

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Discovery of SHR1127, an orally bioavailable, highly potent and selective KRAS G12D inhibitor

CANCER RESEARCH

IF16.6

2024-03-221

PRE

Time-resolved cryo-EM of G-protein activation by a GPCR

Nature

IF48.5

2024-03-130

PRE

Lactobacillus rhamnosus GG ATCC53103 and Lactobacillus plantarum JL01 improved nitrogen metabolism in weaned piglets by regulating the intestinal flora structure and portal vein metabolites

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-06-295

OAAI

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma

肝脏微环境的最新研究进展及肝细胞癌免疫治疗的前沿进展

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-05-1814

OAAI

SHR-A1921, a novel TROP-2 ADC with an optimized design and well-balanced profile between efficacy and safety

SHR-A1921，一种新型的TROP-2 ADC具有优化的设计以及在疗效和安全性之间的良好平衡

CANCER RESEARCH

IF16.6

2023-04-144

PRE

SHR-A1811, a novel anti-HER2 ADC with superior bystander effect, optimal DAR and favorable safety profiles

CANCER RESEARCH

IF16.6

2023-04-1412

PRE

The chromosome-level genome of Eucommia ulmoides provides insights into sex differentiation and a-linolenic acid biosynthesis

杜仲染色体水平的基因组提供了性别分化和a-亚麻酸生物合成的见解

FRONTIERS IN PLANT SCIENCE

IF4.8

2023-03-317

OAAI

Structure determination of inactive-state GPCRs with a universal nanobody

NATURE STRUCTURAL & MOLECULAR BIOLOGY

IF10.1

2022-11-1754

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-05-2019

OAAI

Discovery of SHR2415, a Novel Pyrrole-Fused Urea Scaffold ERK1/2 Inhibitor

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-04-011

Discovery of SHR5133, a Highly Potent and Novel HBV Capsid Assembly Modulator

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-02-177

Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancers

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-01-018

PRE

GDF10 inhibits cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma by the transforming growth factor-β/Smad and NF-κB pathways

CARCINOGENESIS

IF2.9

2021-12-187

PRE

Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-10-135

PREAI

Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors

发现羟基脒衍生物是高效，选择性的Indoleamine-2，3-双加氧酶1抑制剂

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2021-01-204

Feng He

个人简介

教育背景

工作经历

荣誉奖项

研究方向